Vaccinate with Confidence and Finish Strong.
作者信息
Rodewald Lance, Wu Dan, Yin Zundong, Feng Zijian
机构信息
National Immunization Program, Chinese Center for Disease Control and Prevention, Beijing, China.
Chinese Center for Disease Control and Prevention, Beijing, China.
出版信息
China CDC Wkly. 2022 Sep 16;4(37):828-831. doi: 10.46234/ccdcw2022.172.
Abstract
摘要
相似文献
1
Vaccinate with Confidence and Finish Strong.自信接种，善始善终。
China CDC Wkly. 2022 Sep 16;4(37):828-831. doi: 10.46234/ccdcw2022.172.
2
Caregiver's perceptions of COVID-19 vaccination, and intention to vaccinate their children against the disease: a questionnaire based qualitative study.照顾者对新冠病毒疫苗接种的认知以及给其子女接种该疾病疫苗的意愿：一项基于问卷调查的定性研究
Ann Med Surg (Lond). 2023 Aug 9;85(10):4757-4763. doi: 10.1097/MS9.0000000000001165. eCollection 2023 Oct.
3
Trends in adolescent COVID-19 vaccination receipt and parental intent to vaccinate their adolescent children, United States, July to October, 2021.2021 年 7 月至 10 月，美国青少年 COVID-19 疫苗接种率和父母打算为其青少年子女接种疫苗的趋势。
Ann Med. 2022 Dec;54(1):733-742. doi: 10.1080/07853890.2022.2045034.
4
U.S. adults' reasons for changing their degree of willingness to vaccinate against COVID-19.美国成年人改变其接种新冠疫苗意愿程度的原因。
Z Gesundh Wiss. 2023 Jan 20:1-13. doi: 10.1007/s10389-023-01819-2.
5
Factors associated with parental intention to vaccinate their preschool children against COVID-19: a cross-sectional survey in urban area of Jakarta, Indonesia.与父母为学龄前儿童接种新冠疫苗意愿相关的因素：印度尼西亚雅加达市区的一项横断面调查
Clin Exp Vaccine Res. 2023 Jul;12(3):240-248. doi: 10.7774/cevr.2023.12.3.240. Epub 2023 Jul 31.
6
Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021.5-11 岁儿童接种 COVID-19 疫苗意愿的背后原因：2021 年 11 月以色列父母的横断面研究。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2112879. doi: 10.1080/21645515.2022.2112879. Epub 2022 Aug 29.
7
The willingness of parents to vaccinate their children younger than 12 years against COVID-19: a cross-sectional study in Malaysia.家长愿意为 12 岁以下儿童接种 COVID-19 疫苗：马来西亚的一项横断面研究。
BMC Public Health. 2022 Jun 29;22(1):1265. doi: 10.1186/s12889-022-13682-z.
8
Parental motivated helplessness in vaccinating children against COVID-19: Its association with fear, effectiveness and willingness to vaccinate.父母对子女接种 COVID-19 疫苗的无助感：与恐惧、有效性和接种意愿的关系。
J Health Psychol. 2023 Dec;28(14):1345-1358. doi: 10.1177/13591053231170055. Epub 2023 May 15.
9
Parents' perception of COVID-19 risk of infection and intention to vaccinate their children.父母对新冠病毒感染风险的认知以及为孩子接种疫苗的意愿。
Vacunas. 2023 Jan-Mar;24(1):37-44. doi: 10.1016/j.vacun.2022.07.004. Epub 2022 Aug 30.
10
Willingness to vaccinate among adults, and factors associated with vaccine acceptance of COVID-19 vaccines in a nationwide study in Poland between March 2021 and April 2022.2021 年 3 月至 2022 年 4 月期间在波兰进行的一项全国性研究中成年人的疫苗接种意愿，以及与 COVID-19 疫苗接种接受度相关的因素。
Front Public Health. 2023 Dec 4;11:1235585. doi: 10.3389/fpubh.2023.1235585. eCollection 2023.
引用本文的文献
1
Association between friends' hesitancy and personal COVID-19 vaccine hesitancy among Chinese medical staff.医务人员朋友犹豫与个人对 COVID-19 疫苗犹豫的关系。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2344290. doi: 10.1080/21645515.2024.2344290. Epub 2024 Apr 29.
2
Understanding factors affecting Chinese medical staff's fear of receiving the fourth dose of COVID-19 vaccine: A cross-sectional study in Taizhou.理解影响中国医务人员接受第四剂 COVID-19 疫苗恐惧的因素：台州的一项横断面研究。
Hum Vaccin Immunother. 2023 Aug;19(2):2261201. doi: 10.1080/21645515.2023.2261201. Epub 2023 Nov 3.
3
Accelerating into Immunization Agenda 2030 with momentum from China's successful COVID-19 vaccination campaign during dynamic COVID Zero.在中国成功开展新冠肺炎疫苗接种运动的推动下，在动态“零新冠”背景下，加速推进免疫议程 2030。
Infect Dis Poverty. 2023 Oct 16;12(1):96. doi: 10.1186/s40249-023-01151-7.
4
COVID-19 vaccine coverage, safety, and perceptions among patients with diabetes mellitus in China: a cross-sectional study.中国糖尿病患者的 COVID-19 疫苗接种率、安全性和认知情况：一项横断面研究。
Front Endocrinol (Lausanne). 2023 Jun 1;14:1172089. doi: 10.3389/fendo.2023.1172089. eCollection 2023.
5
Immunogenicity and Safety of Homologous Booster Doses of CoronaVac COVID-19 Vaccine in Elderly Individuals Aged 60 Years and Older: A Dosing Interval Study - Yunnan Province, China, 2021-2022.科兴新冠疫苗同源加强针在60岁及以上老年人中的免疫原性和安全性：一项接种间隔研究 - 中国云南省，2021 - 2022年
China CDC Wkly. 2023 Feb 10;5(6):125-130. doi: 10.46234/ccdcw2023.023.
6
Assessing acceptability of the fourth dose against COVID-19 among Chinese adults: A population-based survey.评估中国成年人对第四剂 COVID-19 疫苗的可接受性：一项基于人群的调查。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2186108. doi: 10.1080/21645515.2023.2186108. Epub 2023 Mar 9.
7
Vaccination effects on post-infection outcomes in the Omicron BA.2 outbreak in Shanghai.接种疫苗对上海奥密克戎 BA.2 感染后结局的影响。
Emerg Microbes Infect. 2023 Dec;12(1):e2169197. doi: 10.1080/22221751.2023.2169197.
本文引用的文献
1
Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death.新冠病毒奥密克戎 BA.2 变异株感染、重症和死亡的灭活疫苗和 Ad5-nCoV 新冠疫苗有效性。
BMC Med. 2022 Oct 20;20(1):400. doi: 10.1186/s12916-022-02606-8.
2
Vaccine effectiveness of BNT162b2 and CoronaVac against SARS-CoV-2 Omicron BA.2 infection, hospitalisation, severe complications, cardiovascular disease and mortality in patients with diabetes mellitus: A case control study.BNT162b2和科兴新冠疫苗对糖尿病患者感染新型冠状病毒奥密克戎BA.2、住院、严重并发症、心血管疾病及死亡的疫苗效力：一项病例对照研究
J Infect. 2022 Nov;85(5):e140-e144. doi: 10.1016/j.jinf.2022.08.008. Epub 2022 Aug 17.
3
A case-case study on the effect of primary and booster immunization with China-produced COVID-19 vaccines on prevention of pneumonia and viral load among vaccinated persons infected by Delta and Omicron variants.关于国产 COVID-19 疫苗初免和加强免疫对预防接种者感染 Delta 和 Omicron 变异株后肺炎和病毒载量的病例对照研究。
Emerg Microbes Infect. 2022 Dec;11(1):1950-1958. doi: 10.1080/22221751.2022.2103455.
4
Safety of an inactivated, whole-virion COVID-19 vaccine (CoronaVac) in people aged 60 years or older in Hong Kong: a modified self-controlled case series.在香港，60 岁及以上人群中使用灭活全病毒 COVID-19 疫苗（科兴疫苗）的安全性：一项修改后的自身对照病例系列研究。
Lancet Healthy Longev. 2022 Jul;3(7):e491-e500. doi: 10.1016/S2666-7568(22)00125-8. Epub 2022 Jul 4.
5
Preliminary Study of the Protectiveness of Vaccination Against the COVID-19 in the Outbreak of VOC Omicron BA.2 - Jilin City, Jilin Province, China, March 3-April 12, 2022.2022年3月3日至4月12日中国吉林省吉林市奥密克戎变异株BA.2疫情期间新冠疫苗接种保护效果的初步研究
China CDC Wkly. 2022 May 6;4(18):377-380. doi: 10.46234/ccdcw2022.081.
6
Effectiveness of BBIBP-CorV vaccine against severe outcomes of COVID-19 in Abu Dhabi, United Arab Emirates.BBIBP-CorV 疫苗对阿联酋阿布扎比 COVID-19 重症结局的有效性。
Nat Commun. 2022 Jun 9;13(1):3215. doi: 10.1038/s41467-022-30835-1.
7
Association of COVID-19 Vaccination and Clinical Severity of Patients Infected with Delta or Omicron Variants - China, May 21, 2021-February 28, 2022.2021年5月21日至2022年2月28日中国新冠病毒德尔塔或奥密克戎变异株感染患者的新冠病毒疫苗接种情况与临床严重程度的关联
China CDC Wkly. 2022 Apr 8;4(14):293-297. doi: 10.46234/ccdcw2022.074.
8
CoronaVac vaccine is effective in preventing symptomatic and severe COVID-19 in pregnant women in Brazil: a test-negative case-control study.科兴新冠疫苗在巴西对有症状和重症 COVID-19 孕妇有效：一项病例对照研究。
BMC Med. 2022 Apr 5;20(1):146. doi: 10.1186/s12916-022-02353-w.
9
The Concept of Classical Herd Immunity May Not Apply to COVID-19.经典群体免疫概念可能不适用于新冠病毒。
J Infect Dis. 2022 Aug 24;226(2):195-198. doi: 10.1093/infdis/jiac109.
10
Global disparities in public health guidance for the use of COVID-19 vaccines in pregnancy.全球在 COVID-19 疫苗接种妊娠应用的公共卫生指导方面存在差异。
BMJ Glob Health. 2022 Feb;7(2). doi: 10.1136/bmjgh-2021-007730.
Zotero 插件